These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15218822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance.
    Fed Regist; 2000 Sep 29; 65(190):58346-50. PubMed ID: 11503646
    [Abstract] [Full Text] [Related]

  • 7. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ, Clauson KA.
    J Herb Pharmacother; 2005 Sep 29; 5(3):67-86. PubMed ID: 16520299
    [Abstract] [Full Text] [Related]

  • 8. FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1999 Aug 06; (No 324):3-4. PubMed ID: 11366575
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ.
    J Am Diet Assoc; 1999 Jul 06; 99(7):797-8. PubMed ID: 10405675
    [No Abstract] [Full Text] [Related]

  • 11. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ.
    Thromb Res; 2005 Jul 06; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FDA has substantial and sufficient authority to regulate dietary supplements.
    McNamara SH, Siegner AW.
    Food Drug Law J; 2002 Jul 06; 57(1):15-24. PubMed ID: 12118477
    [No Abstract] [Full Text] [Related]

  • 15. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH.
    Food Drug Law J; 1996 Jul 06; 51(2):313-8. PubMed ID: 11822323
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ.
    Thromb Res; 2005 Jul 06; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract] [Full Text] [Related]

  • 20. Sources of energy and nutrients in the diets of infants and toddlers.
    Fox MK, Reidy K, Novak T, Ziegler P.
    J Am Diet Assoc; 2006 Jan 06; 106(1 Suppl 1):S28-42. PubMed ID: 16376628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.